E-ISSN 2149-388X | ISSN 2149-0430
 

Case Report 


Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay.

SUPPLEMENTARY FILES :

  • 135-1465934492-adt-1.docx ()
  • Abstract
    Background: Fluid and electrolyte disturbances, especially hyponatremia are common complications after pituitary surgeries. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the leading cause of hyponatremia in hospitals. Fluid restriction is the first step in treatment of SIADH. In rare cases vasopressin receptor inhibitors might be useful for medical treatment.
    Case Presentation: In this paper, we present a case of SIADH after a pituitary surgery with an unpredictable effect of tolvaptan.
    Conclusion: Tolvaptan is the most preferred agent for the treatment of SIADH nowadays. However tolvaptan might cause unpredictable situations in the course of treatment that clinicians must be very careful and in close follow
    up the patient.

    Key words: Hypernatremia, hyponatremia, pituitary surgery, SIADH, tolvaptan


     
    ARTICLE TOOLS
    Abstract
    PDF Fulltext
    How to cite this articleHow to cite this article
    Citation Tools
    Related Records
     Articles by Suleyman Karakose
    Articles by Ayse Zeynep Bal
    Articles by Selman Unverdi
    Articles by Murat Duranay
    on Google
    on Google Scholar


    How to Cite this Article
    Pubmed Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. 2016; 2(3): 154-156. doi:10.5455/umj.20160703095035


    Web Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. https://www.ulutasmedicaljournal.com/?mno=232578 [Access: March 26, 2023]. doi:10.5455/umj.20160703095035


    AMA (American Medical Association) Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. 2016; 2(3): 154-156. doi:10.5455/umj.20160703095035



    Vancouver/ICMJE Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. (2016), [cited March 26, 2023]; 2(3): 154-156. doi:10.5455/umj.20160703095035



    Harvard Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay (2016) Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J, 2 (3), 154-156. doi:10.5455/umj.20160703095035



    Turabian Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. 2016. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. THE ULUTAS MEDICAL JOURNAL, 2 (3), 154-156. doi:10.5455/umj.20160703095035



    Chicago Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. "Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?." THE ULUTAS MEDICAL JOURNAL 2 (2016), 154-156. doi:10.5455/umj.20160703095035



    MLA (The Modern Language Association) Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. "Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?." THE ULUTAS MEDICAL JOURNAL 2.3 (2016), 154-156. Print. doi:10.5455/umj.20160703095035



    APA (American Psychological Association) Style

    Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay (2016) Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. THE ULUTAS MEDICAL JOURNAL, 2 (3), 154-156. doi:10.5455/umj.20160703095035